ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,900, issued on March 4, was assigned to IDEXX Laboratories Inc. (Westbrook, Maine).
"Markers for renal disease" was invented by Mahalakshimi Yerramilli (Falmouth, Maine), Michael Randolph Atkinson (Gorham, Maine) and Murthy V. S. N. Yerramilli (Falmouth, Maine).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides a...